Steven Romano Insider Profile
4 Followers
Steven Romano, Director at Dianthus Therapeutics, holds ― shares in Dianthus Therapeutics (Ticker: DNTH), holds 0.00 shares in Mallinckrodt (Ticker: MNKKQ), holds ― shares in Silence Therapeutics (Ticker: SLN).
Steven Romano's Trading History
You May Also Like
Steven Romano insider profile FAQ
What is the percentage of profitable transactions made by Steven Romano?
The percentage of profitable transactions made by Steven Romano is 0%.
What is the average return per transaction made by Steven Romano?
The average return per transaction made by Steven Romano is -26.80%.
What stocks does Steven Romano hold?
Steven Romano holds: DNTH, MNKKQ, SLN stocks.
What was Steven Romano's most profitable transaction?
Steven Romano’s most profitable transaction was an Informative Buy of MNKKQ stock on May 9, 2016. The return on the trade was -25.50%.
What is Steven Romano's role in Dianthus Therapeutics?
Steven Romano's role in Dianthus Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
